Abbott, Medtronic to Battle Over Patent

Abbott files lawsuit against Medtronic over Rapid Exchange system

Abbott has filed a lawsuit against Medtronic for infringing on its patent for the Rapid Exchange system.

The lawsuit comes on the heels of Medtronic’s announcement that it is launching its Endeavor drug-eluting stent and other angioplasty products in the US on the Rapid Exchange delivery system, which it anticipates will increase use of its devices, Medtronic said.

Abbott said its Xience V drug-eluting stent has rapidly become the US market leader. It does not expect Medtronic’s launch of a new delivery system to change market dynamics.

SOURCE: FDA NEWS

Add us as a preferred source on Google

Get the latest Medical Product Outsourcing news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Medical Product Outsourcing Newsletters